Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Jardin

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Biomedicines|September 23, 2022
NFkB Pathway and Hodgkin LymphomaFabrice Jardin
Expert Review of Clinical Immunology|May 19, 2010
Development of autoimmunity in lymphomaFabrice Jardin
Discovery Medicine|August 6, 2014
Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapyFabrice Jardin
Current Opinion in Oncology|July 16, 2013
MicroRNAs in lymphoma, from diagnosis to targeted therapyFabrice Jardin, Martin Figeac
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Cell-Free DNA for the Management of Classical Hodgkin LymphomaVincent Camus, Fabrice Jardin
Blood|June 1, 2013
TP53 and outcome in DLBCL: not only the coding regionFabrice Jardin, Bertrand Coiffier
Expert Review of Hematology|December 15, 2015
The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapiesSydney Dubois, Fabrice Jardin
Pharmacogenomics|November 9, 2019
Cell-free DNA and the monitoring of lymphoma treatmentVincent Camus, Fabrice Jardin
Hematology (Amsterdam, Netherlands)|July 16, 2005
Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesisFabrice Jardin, Surinder S Sahota
Expert Review of Molecular Diagnostics|April 19, 2017
The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potentialVincent Camus, Fabrice Jardin, Herve Tilly
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Biomedicines|September 23, 2022
NFkB Pathway and Hodgkin LymphomaFabrice Jardin
Expert Review of Clinical Immunology|May 19, 2010
Development of autoimmunity in lymphomaFabrice Jardin
Discovery Medicine|August 6, 2014
Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapyFabrice Jardin
Current Opinion in Oncology|July 16, 2013
MicroRNAs in lymphoma, from diagnosis to targeted therapyFabrice Jardin, Martin Figeac
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Cell-Free DNA for the Management of Classical Hodgkin LymphomaVincent Camus, Fabrice Jardin
Blood|June 1, 2013
TP53 and outcome in DLBCL: not only the coding regionFabrice Jardin, Bertrand Coiffier
Expert Review of Hematology|December 15, 2015
The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapiesSydney Dubois, Fabrice Jardin
Pharmacogenomics|November 9, 2019
Cell-free DNA and the monitoring of lymphoma treatmentVincent Camus, Fabrice Jardin
Hematology (Amsterdam, Netherlands)|July 16, 2005
Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesisFabrice Jardin, Surinder S Sahota
Expert Review of Molecular Diagnostics|April 19, 2017
The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potentialVincent Camus, Fabrice Jardin, Herve Tilly
Pageof 23